CBD / Hemp

NutraVideo: Dr. Stuart Titus on CBN for sleep

NutraVideo: Dr. Stuart Titus on CBN for sleep

By Danielle Masterson

As the excitement over CBD levels out, many are turning their attention to CBN. The minor cannabinoid is especially appealing to many tired Americans, as it makes name for itself as a sedative.

Getty Images / Nevodka

Congress extends hemp pilot program

By Danielle Masterson

The Senate passed a continuing resolution Wednesday that provides short term funding in a move that will prevent a government shutdown. The resolution also included the House’s language to extend the hemp pilot program through September of 2021.

Getty Images / gustavofrazao

Sleep, immune support define September product launches

By Danielle Masterson

As the weather cools down and we get back into routines, brands are launching products that offer sleep and immune support and even candy flavored protein to get consumers into the Halloween spirit.

NutraVideo: GRMA on staying on the same compliance page

NutraVideo: GRMA on staying on the same compliance page

By Danielle Masterson

It was hard enough keeping everyone on the same compliance page and then along came COVID-19. During the pandemic, FDA has published dozens of guidance documents for the dietary supplement industry as well as other stakeholders.

© jessicahyde / Getty Images

Trade groups unite to support new Hemp-CBD bill

By Stephen Daniells

Multiple hemp and dietary supplement industry trade groups have written to Reps. Kurt Schrader (D-OR) and Morgan Griffith (R-VA) to thank them for their leadership on the hemp-CBD issue.

© UrosPoteko / Getty Images

Hemp-CBD dietary supplement bill introduced in the House

By Stephen Daniells

Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.

A growing number of firms are using genetically engineered yeast to biosynthesize cannabinoids by effectively reverse engineering how Cannabis sativa plants make these molecules (picture: Demetrix)

Demetrix begins demo scale production of rare cannabinoid CBG

By Elaine Watson

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...

© Getty Images Esther Kelleter

AHPA event aims to guide CBD industry

By Danielle Masterson

Products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.

© Getty Images KatarzynaBialasiewicz

CBD for mood: Going green to ease the blues

By Danielle Masterson

During these unprecedented times, many are undergoing a great amount of stress, leading many to seek out natural products to manage stress and boost their mood.

What's happening in the UK & EU for CBD?

What's happening in the UK & EU for CBD?

By Stephen Daniells

With the UK and the European Union now on divergent paths because of Brexit, what is the state of play for regulating hemp and CBD across the pond and where are the opportunities?

Is FDA open to entertaining an NDI for CBD products?

Is FDA open to entertaining an NDI for CBD products?

By Stephen Daniells

The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).

NPA Fabricant on CBD, NDIs, FDA resuming inspections

NPA Fabricant on CBD, NDIs, FDA resuming inspections

By Stephen Daniells

FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.

Follow us

Products

View more

Webinars